Hints and tips:
Related Special Reports
...Gilead has worked with scientists at Accelerated Clinical Trials Ltd to develop a blood cancer treatment....
...As healthcare systems around the world put pressure on drug prices, pharma companies are also looking for ways to cut costs in research and development....
...Astellas Pharma bought eye-treatment specialist Iveric Bio in a $5.9bn deal in May. Mizuho splashed out $550mn for US boutique investment bank Greenhill & Co....
...Japanese pharma group Eisai said new analysis found 60 per cent of patients at the very early stages of Alzheimer’s showed a clinical improvement after taking its drug Leqembi for 18 months, compared to...
...We’ve got an organisation filled with experts in their field led by some of the biggest leaders in global diagnostics, global pharma and global life sciences.”...
Daiichi Sankyo and AstraZeneca’s Enhertu could double time patients can live without their condition progressing
...Amid expectations of booming demand for fever medicine and other drugs, mainland China-listed shares of pharma companies Guangzhou Baiyunshan Pharmaceutical and Hualan Biological Engineering each gained...
...Gilead SciencesO: 6; L: 8; I: 7; Total: 21The South Korean legal team at the US-based pharma group increased self-service on legal issues in the rest of the business....
...Kevin Gorman, senior vice-president at German pharma giant Merck, a key supplier to the chip industry, says the company’s scientists have been working on PFAS-free alternatives since 2020....
...“When you watch a horrendously large percentage of your assets disappear out of the door within an extraordinarily short period of time, you vow that you would never allow this to happen,” co-founder Ian...
...As pharma blogger Derek Lowe pointed out, the drug removes plaques but doesn’t slow the disease all that much. Worse, clearing the plaques carries risks....
...Shares in Biogen and Eisai surged on Wednesday after the pharma groups said they would apply for regulatory approval for a new Alzheimer’s drug following a late-stage clinical trial that showed it slowed...
...The head of pharma company Sanofi said UK economic policy meant the country was falling behind in healthcare innovation....
Authorisation allows jab to be deployed by Covax in boost for Chinese pharma industry
...He used to be the chief of French pharma giant Sanofi. Millennium Management, the multi-strategy hedge fund, has hired Justin Gmelich from King Street as its new co-chief investment officer....
...International co-operation is desperately needed to solve this market failure....
...Under a three-year business plan unveiled last month, the company will invest ¥100bn in research and development or to expand factories in the health science and pharma sectors, and ¥80bn in its beer and...
...Tara Hansen, a consultant at Informa Pharma Custom Intelligence, said the trial results were “groundbreaking” and would position Enhertu as a competitive option in a patient population with a high unmet...
...Moderna is fighting a shareholder proposal demanding the pharma group open up its Covid-19 vaccine technology to poorer countries and explain why its prices are so high given the amount of government assistance...
...South Korean ecommerce group Coupang has appointed Pedro Franceschi, co-founder and co-chief executive of corporate card fintech start-up Brex, to its board of directors....
...The German drugmaker has sought to enter the Chinese market through a distribution partnership with China’s Fosun Pharma....
...Flynn Pharma did not respond to a request for comment....
...The state-owned pharma group’s move comes as concerns grow over the efficacy of conventional inactivated virus vaccines, which have dominated the rollout in China....
...Drugs from rival pharma groups Eli Lilly and Roche may also enter the market earlier than expected....
...Schwarzman and co disclose their carried interest....
International Edition